HB 2697 allows pharmacists, health departments, and healthcare providers to dispense or distribute expired FDA-approved naloxone (an opioid overdose reversal medication) to individuals at risk of overdose, their families, or community organizations that assist them. The bill defines "expired opioid antagonist" as medication with an expiration date within five years of use, expanding access to this critical tool. It provides immunity from liability for professionals acting in good faith while following protocols, including instructing users to call emergency services after administration. This policy directly affects people at risk of opioid overdose, pharmacists, healthcare providers, and community health programs distributing naloxone.